Skip to main content
Liven Pharma Limited logo

Liven Pharma Limited — Investor Relations & Filings

Ticker · LIVEN ISIN · PK0055101015 PSX Manufacturing
Open in API
Filings indexed 40 across all filing types
Latest filing 2025-11-05 Regulatory Filings
Country PK Pakistan
Listing PSX LIVEN

About Liven Pharma Limited

https://liven-pharma.com/

Liven Pharma Limited manufactures and markets a range of pharmaceutical and allied healthcare products. The company is dedicated to developing, producing, and distributing safe, effective, and high-quality medicines to enhance health and improve quality of life. Initially operating as Landmark Spinning Industries Limited, the company underwent a strategic transformation, shifting its primary business focus from yarn manufacturing to the pharmaceutical sector. Liven Pharma serves its established markets and has expanded its operations to include exports to the Arab region.

Recent filings

Filing Released Lang Actions
Notice of Annual General Meeting for the year ended June 30, 2025
Regulatory Filings
2025-11-05 English
Board Meeting For Consideration of Annual Accounts For The Year Ended June 30, 2025.
Regulatory Filings
2025-10-29 English
Material Information
Regulatory Filings Classification · 95% confidence The document text is extremely short (66 characters) and contains no substantive content, financial data, or any indication of report type. It only mentions 'CamScanner' and an omitted picture, which is insufficient to classify as any specific financial report or announcement. Given the lack of content, the document best fits the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2025-10-02 English
Material Information
Regulatory Filings Classification · 95% confidence The document text is extremely short (66 characters) and contains no substantive content, financial data, or any indication of report type. It only mentions 'CamScanner' and an omitted picture, which is insufficient to classify as any specific financial or regulatory report. Given the lack of content, the document best fits the fallback category for miscellaneous or non-informative filings, which is Regulatory Filings (RNS).
2025-10-02 English
Material Information
Capital/Financing Update Classification · 100% confidence The document is titled as an 'Offer Document' related to a rights issue by Liven Pharma Limited. It contains detailed information about the rights issue, including the number of shares offered, pricing, underwriting details, legal undertakings, risk factors, and financial highlights. The document is comprehensive and intended to inform shareholders and the public about the capital raising through issuance of new shares. This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising and capital structure changes. The document is not an announcement of a report but the actual offer document itself, and it is not a general regulatory filing or a report publication announcement. Therefore, the correct classification is CAP with high confidence.
2025-10-02 English
EXTRACT OF RESOLUTIONS PASSED AT THE EOGM OF LIVEN PHARMA LIMITED (THE COMPANY) HELD ON 18.08.2025 ON 11:30AM AT 49 KM MULTAN ROAD LAHORE
Regulatory Filings Classification · 100% confidence The document text is extremely short (132 characters) and contains no substantive content, financial data, or any indication of report type. It only mentions 'CamScanner' and omitted pictures, which suggests it is not a financial or regulatory filing. Given the lack of content, the document does not fit any specific filing category and defaults to Regulatory Filings (RNS) as a fallback category.
2025-08-18 English

Browse filings by year

2 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.